SNT 10.3% 4.3¢ syntara limited

Pharmaxis has $25m cash, $10m PPE, and another $10m milestone...

  1. 43 Posts.
    lightbulb Created with Sketch. 49
    Pharmaxis has $25m cash, $10m PPE, and another $10m milestone payment looking likely by june.
    Liabilities are really only $9m lease, $3m accounts payable and $2m other (excluded the $23m to novaquest because that is dependent on future revenues)

    That gives me a rough book value of $45m - $14m = $31m

    Currently pharmaxis is trading at $45m.

    Question is, would you buy their entire portfolio of drugs for $14m?

    I would. Boerhinger Ingelheim definitely would.

    That's why I bought in today!
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.